Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
21.07
+0.09 (0.43%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sarepta Therapeutics Analyst Ratings
Total Analysts
29
Consensus Rating
Hold
Price Target
$25.85
Upside
+22.69%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $5 | Strong Sell | Reiterates | $5 | -76.27% | Apr 16, 2026 |
| Citigroup | Citigroup | Strong Sell Maintains $9 → $13 | Strong Sell | Maintains | $9 → $13 | -38.30% | Mar 26, 2026 |
| Needham | Needham | Sell Reiterates n/a | Sell | Reiterates | n/a | n/a | Mar 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $37 | Buy | Reiterates | $37 | +75.61% | Mar 19, 2026 |
| Mizuho | Mizuho | Buy Maintains $26 → $31 | Buy | Maintains | $26 → $31 | +47.13% | Mar 13, 2026 |
| Citigroup | Citigroup | Strong Sell Maintains $8 → $9 | Strong Sell | Maintains | $8 → $9 | -57.29% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $5 | Strong Sell | Reiterates | $5 | -76.27% | Mar 2, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $45 → $38 | Buy | Maintains | $45 → $38 | +80.35% | Feb 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $5 | Strong Sell | Reiterates | $5 | -76.27% | Jan 27, 2026 |
| Wedbush | Wedbush | Buy Maintains $32 → $34 | Buy | Maintains | $32 → $34 | +61.37% | Jan 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $5 | Strong Sell | Reiterates | $5 | -76.27% | Jan 14, 2026 |
| Wedbush | Wedbush | Buy Initiates $32 | Buy | Initiates | $32 | +51.87% | Dec 9, 2025 |
| Barclays | Barclays | Hold Maintains $22 → $20 | Hold | Maintains | $22 → $20 | -5.08% | Nov 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $45 | Buy | Maintains | $50 → $45 | +113.57% | Nov 5, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $22 → $19 | Strong Buy | Maintains | $22 → $19 | -9.82% | Nov 5, 2025 |
| Mizuho | Mizuho | Hold → Buy Upgrades $19 → $26 | Hold → Buy | Upgrades | $19 → $26 | +23.40% | Nov 5, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.